Document is current
Any future updates will be listed below
-
Authors
Yan, Shixin
Kong, Chuipeng
Cheng, Jiazhe
Tang, Zhuoyun
Sun, Ke
Chen, Shanchuan
Li, Minghan
Tao, Chengyan
Li, Yue
Zhao, Yanhua
Tao, Chuanmin
Geng, Jia https://orcid.org/0000-0003-4753-1039
Li, Feng
-
Funding
Funding for this research was provided by:
the National Key Research and Development Program of China (No. 2022YFB3205600)
the Key-Area Research and Development Program of Guangdong Province (No. 2023B0101200014)
1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC23015)
the National Key R&D Program of China (2023YFB3208303)
the National Natural Science Foundation of China (22204112, 22074099)
the Science and Technology Major Project of Tibetan Autonomous Region of China (XZ202201ZD0001G)
the Institutional Research Fund from Sichuan University (2021SCUNL105)
National Natural Science Foundation of China (32301258)
China Postdoctoral Science Foundation (2024M752201)
- License Information
-
More Information
Article History
Received: 21 March 2025
Revised: 27 May 2025
Accepted: 28 May 2025
First Online: 8 August 2025
Declarations
:
: Clinical Serum samples from HBV patients and healthy individuals were provided by West China Hospital of Sichuan University (Chengdu, China), and the clinical experiments involved in this study were approved by the Biomedical Ethics Committee of West China Hospital of Sichuan University (approval number: 20241192). Written informed consent was obtained from all participants.
: All authors have consented to the publication of the data covered in this article.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
